Metastatic Hepatocellular Carcinoma Responsive to Pembrolizumab

Hepatocellular carcinoma (HCC) is an aggressive liver tumor that occurs with chronic liver disease. Surgical resection is the mainstay of therapy for localized disease whereas therapeutic options for advanced disease are limited. The innovative blockade of immune checkpoints with targeted immunother...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Phu, Rahal, Ahmad, Kallail, K. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934853/
https://www.ncbi.nlm.nih.gov/pubmed/27433410
http://dx.doi.org/10.7759/cureus.631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934853/
https://www.ncbi.nlm.nih.gov/pubmed/27433410
http://dx.doi.org/10.7759/cureus.631

Ejemplares similares